secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K
Filed at:   2026-06-11T21:16:14+00:00
Accession:  0001790340-26-000062
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering stockholders elect Feinberg and Keating as Class II directors, ratify RSM US LLP as auditor
--------------------------------------------------------------------------------

- Peter Feinberg elected with 26,420,287 votes for, 2,008,073 withheld; Laurie B. Keating with 27,121,501 for, 1,306,859 withheld.
- Ratification of RSM US LLP as independent auditor for 2026: 42,142,848 for, 1,920,218 against, 431,993 abstain; no broker non-votes.
- Total 44,495,059 shares present (68.8% of outstanding) as of April 15, 2026 record date; broker non-votes of 16,066,699 on director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000179034026000062/0001790340-26-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000179034026000062/imrx-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001790340-26-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer